Body Recomposition Phase 3
The main weight loss goal has been met. ~195 lb and <15% body fat. Now it's time to lean down from 15% body fat to sub 12%. While nursing a shoulder and opposite elbow injury.
198 lbs
70 in
male
By
Weight
GLP-2
Metabolic
Growth
tes
Metabolic
Healing
ghk
Longevity
Healing
wol
Longevity
For research purposes only.
Peptide Mind does not endorse this protocol. This is a user-generated research reference — not for human consumption or therapeutic use.
Log your research schedule
Add this research protocol to your calendar or print a reference copy for your lab records. For research purposes only.
Peptide Protocol Schedule
A day-by-day view of this protocol. Tap any day to see which peptides are active. Circle size reflects how many peptides are scheduled; colored dots below represent individual peptides.
tes
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
evening
subcutaneous
600 mcg
ghk
GHK-Cu
evening
subcutaneous
2 mg
wol
Wolverine Blend (BPC-157, TB-500)
evening
subcutaneous
400 mcg
Daily Dosing Breakdown
A grouped breakdown of which peptides to take throughout this protocol. Consecutive days with the same schedule are combined. Days with no doses are omitted.
Jul 22–24, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Jul 25–26, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Jul 27, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Jul 28–31, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 1–2, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 3, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 4–7, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 8–9, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 10, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 11–14, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 15–16, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 17, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 18–21, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 22–23, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 24, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 25–28, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 29–30, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Aug 31, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 1–4, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 5–6, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 7, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 8–11, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 12–13, 2026
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 14, 2026
GLP-2 (Tirzepatide) — 5 mg · Morning
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
GHK-Cu — 2 mg · Evening
Wolverine Blend (BPC-157, TB-500) — 400 mcg · Evening
Sep 15–18, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
Sep 21–25, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
Sep 28 – Oct 2, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
Oct 5–9, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
Oct 12, 2026
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) — 600 mcg · Evening
Weekly Schedule
Day-of-week breakdown for each peptide in this protocol.
GLP-2
GLP-2 (Tirzepatide)
morning
subcutaneous
5 mg
- Cycle Duration
- 7 weeks 6 days
tes
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
evening
subcutaneous
600 mcg
- Cycle Duration
- 11 weeks 6 days
ghk
GHK-Cu
evening
subcutaneous
2 mg
- Cycle Duration
- 7 weeks 6 days
wol
Wolverine Blend (BPC-157, TB-500)
evening
subcutaneous
400 mcg
- Cycle Duration
- 7 weeks 6 days
Total Peptide Requirements
The total quantity of each peptide needed to complete this protocol, calculated from dosage and duration.
Weight
GLP-2
Metabolic
GLP-2 (Tirzepatide)
5 mg · weekly · Morning
Growth
tes
Metabolic
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
0.6 mg · 5× weekly · Evening
Skin
ghk
Longevity
GHK-Cu
2 mg · 5× weekly · Evening
Healing
wol
Longevity
Wolverine Blend (BPC-157, TB-500)
0.4 mg · 7× weekly · Evening
Know exactly what to draw
Enter your vial concentration and we'll calculate the precise injection volume for every peptide in this protocol.
Protocol Body Targets
The biological systems and tissue targets addressed by the 4 peptides in this protocol.
6
Body Targets
4 peptides
Metabolic
Regulates fat metabolism, insulin sensitivity, and energy use.
GLP-2 (Tirzepatide), Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
Gut
Supports gut lining integrity, digestion, and the gut-brain axis.
GLP-2 (Tirzepatide), Wolverine Blend (BPC-157, TB-500)
Hormones
Influences hormone signaling pathways and endocrine balance.
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
Skin
Promotes collagen synthesis, wound healing, and skin elasticity.
GHK-Cu
Muscle
Enhances muscle growth, repair, and recovery after exercise.
Wolverine Blend (BPC-157, TB-500)
Joints & Bone
Supports cartilage integrity, bone density, and joint mobility.
Wolverine Blend (BPC-157, TB-500)
Protocol targeted areas
Build your own protocol
Create a custom peptide stack tailored to your goals. Add peptides, set dosages, and share it with the community.
Protocol Duration & Timeline
A visual breakdown of each peptide's active window within this protocol. Use this to understand the total cycle length and how each compound's duration compares to the full protocol.
GLP-2 (Tirzepatide)
5 mg once per week
- 55 days
Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)
600 mcg 5x per week
- 83 days
GHK-Cu
2 mg 5x per week
- 55 days
Wolverine Blend (BPC-157, TB-500)
400 mcg 7x per week
- 55 days
Protocol Peptides
Each peptide included in this protocol with its dosing amount, frequency, and administration details.
Weight
GLP-2
Metabolic
Growth
tes
Metabolic
Healing
wol
Longevity
Browse other protocols
View allWeight
GLP-3
Weight
tesa
Healing
ghk
Healing
bpc
Weight
cjc
Frequently asked questions
What is a peptide dosage calculator?
A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringe units to draw. This calculator works for single peptide compounds and multi-peptide blends.
How do I calculate peptide dosage from a vial?
To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.
How much Bacteriostatic water should I add to a peptide vial?
Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.
How are peptides different from proteins?
Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.